CEFTAROLINE: 322 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
322
Total FAERS Reports
88 (27.3%)
Deaths Reported
183
Hospitalizations
322
As Primary/Secondary Suspect
45
Life-Threatening
3
Disabilities
First Report: 20120106 · Latest Report: 20250101
What Are the Most Common CEFTAROLINE Side Effects?
#1 Most Reported
Drug ineffective
70 reports (21.7%)
#2 Most Reported
Acute kidney injury
39 reports (12.1%)
#3 Most Reported
Off label use
33 reports (10.2%)
All CEFTAROLINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 70 | 21.7% | 29 | 45 |
| Acute kidney injury | 39 | 12.1% | 12 | 28 |
| Off label use | 33 | 10.3% | 8 | 22 |
| Toxic epidermal necrolysis | 27 | 8.4% | 23 | 19 |
| Thrombocytopenia | 22 | 6.8% | 3 | 13 |
| Treatment failure | 22 | 6.8% | 18 | 19 |
| Neutropenia | 18 | 5.6% | 0 | 10 |
| Pyrexia | 18 | 5.6% | 4 | 9 |
| Rash | 18 | 5.6% | 0 | 6 |
| Drug reaction with eosinophilia and systemic symptoms | 17 | 5.3% | 8 | 12 |
| Stevens-johnson syndrome | 15 | 4.7% | 10 | 12 |
| Staphylococcal bacteraemia | 13 | 4.0% | 9 | 10 |
| Tubulointerstitial nephritis | 13 | 4.0% | 6 | 12 |
| Agranulocytosis | 12 | 3.7% | 0 | 11 |
| Blood creatinine increased | 11 | 3.4% | 3 | 9 |
| Condition aggravated | 11 | 3.4% | 4 | 7 |
| Eosinophilia | 11 | 3.4% | 0 | 9 |
| Septic shock | 11 | 3.4% | 11 | 9 |
| Infection | 10 | 3.1% | 6 | 7 |
| Multiple organ dysfunction syndrome | 10 | 3.1% | 10 | 4 |
Who Reports CEFTAROLINE Side Effects? Age & Gender Data
Gender: 31.3% female, 68.7% male. Average age: 58.2 years. Most reports from: US. View detailed demographics →
Is CEFTAROLINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 4 | 3 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 9 | 0 | 7 |
| 2015 | 13 | 0 | 7 |
| 2016 | 8 | 0 | 5 |
| 2017 | 9 | 0 | 7 |
| 2018 | 14 | 6 | 7 |
| 2019 | 5 | 0 | 2 |
| 2020 | 9 | 1 | 4 |
| 2021 | 8 | 1 | 3 |
| 2022 | 6 | 0 | 4 |
| 2023 | 9 | 0 | 7 |
| 2024 | 7 | 0 | 5 |
| 2025 | 1 | 0 | 1 |
What Is CEFTAROLINE Used For?
| Indication | Reports |
|---|---|
| Staphylococcal infection | 56 |
| Staphylococcal bacteraemia | 42 |
| Product used for unknown indication | 31 |
| Endocarditis | 19 |
| Endocarditis staphylococcal | 16 |
| Pneumonia | 14 |
| Infection | 13 |
| Bacteraemia | 12 |
| Meningitis | 11 |
| Osteomyelitis | 11 |
CEFTAROLINE vs Alternatives: Which Is Safer?
CEFTAROLINE vs CEFTAROLINE FOSAMIL
CEFTAROLINE vs CEFTAZIDIME
CEFTAROLINE vs CEFTIBUTEN
CEFTAROLINE vs CEFTOLOZANE\TAZOBACTAM
CEFTAROLINE vs CEFTRIAXONE
CEFTAROLINE vs CEFTRIAXONE\CEFTRIAXONE
CEFTAROLINE vs CEFUROXIME
CEFTAROLINE vs CEFUROXIME AXETIL
CEFTAROLINE vs CELEBREX
CEFTAROLINE vs CELECOXIB
Official FDA Label for CEFTAROLINE
Official prescribing information from the FDA-approved drug label.